The contribution of DNA apurinic/apyrimidinic endonuclease genotype and smoking habit to taiwan lung cancer risk

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2775-2778

  Chen, Wei Chun ^a,b   Tsai, Chia Wen ^a,b   Hsia, Te Chun ^a,b   Chang, Wen Shin ^a,b   Lin, Liang Yi ^a   Liang, Shinn Jye ^a   Tu, Chih Yen ^a   Cheng, Wei Erh ^a   Chen, Hung Jen ^a   Wang, Shu Ming ^a   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

APEX1; Lung cancer; Single nucleotide polymorphism; Smoking habit; Taiwanese

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; APEX1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING HABIT; TAIWAN; APEX1; CASE CONTROL STUDY; DNA REPAIR; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; LUNG TUMOR; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE-NUCLEOTIDE POLYMORPHISM; SMOKING; TAIWANESE;

APEX1; LUNG CANCER; SINGLE-NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TAIWANESE;

CASE-CONTROL STUDIES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; TAIWAN;

MLCS; MLOWN;

EID: 84881353514     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Hecht SS: Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol 3: 461-469, 2002.
3. Shields PG: Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876, 2002.
4. Shields PG and Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18: 2309-2315, 2000.
5. Spitz MR, Wei Q, Dong Q, Amos CI and Wu X: Genetic susceptibility to lung cancer: The role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-698, 2003.
6. Fleck O and Nielsen O: DNA repair. J Cell Sci 117: 515-517, 2004.
7. Liu Y, Prasad R, Beard WA, Kedar PS, Hou EW, Shock DD and Wilson SH: Coordination of steps in single-nucleotide base excision repair mediated by apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta. J Biol Chem 282: 13532-13541, 2007.
8. Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S and Mitra S: Requirement for human AP endonuclease 1 for repair of 3'-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogenesis 21: 1329-1334, 2000.
9. Tell G, Damante G, Caldwell D and Kelley MR: The intracellular localization of APE1/REF1: More than a passive phenomenon? Antioxid Redox Signal 7: 367-384, 2005.
10. Lin CH, Chen PM, Cheng YW, Chen CY, Yuan CJ and Lee H: The APE1 Asp/Asp genotype and the combination of APE1 Asp/Asp and hOGG1-Cys variants are associated with increased p53 mutation in non-small cell lung cancer. J Epidemiol 22: 537-542, 2012.
11. Chang WS, Tsai CW, Cheng KH, Lien CS, Huang CP, Liao WL, Lee MH, Wu HC, Chang CH, Lin CC and Bau DT: The role of APEX1/REF1 (apurinic/apyrimidic endonuclease DNA-repair gene) in renal cell carcinoma. Adapt Med 4: 216-223, 2012.
12. Chang WS, Ke HL, Tsai CW, Lien CS, Liao WL, Lin HH, Lee MH, Wu HC, Chang CH, Chen CC, Lee HZ and Bau DT: The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma. Anticancer Res 32: 3855-3860, 2012.
13. Chang WS, Yang MD, Tsai CW, Cheng LH, Jeng LB, Lo WC, Lin CH, Huang CY and Bau DT: Association of cyclooxygenase 2 single-nucleotide polymorphisms and hepatocellular carcinoma in Taiwan. Chin J Physiol 55: 1-7, 2012.
14. Hsia TC, Liu CJ, Chu CC, Hang LW, Chang WS, Tsai CW, Wu CI, Lien CS, Liao WL, Ho CY and Bau DT: Association of DNA double-strand break gene XRCC6 genotypes and lung cancer in Taiwan. Anticancer Res 32: 1015-1020, 2012.
15. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen KY, Chen YM, Huang MS, Hu CY, Chen CJ and Hsiung CA: A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 18: 223-229, 2009.
16. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J and Thierens H: Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 631: 101-110, 2007.
17. Deng Q, Sheng L, Su D, Zhang L, Liu P, Lu K and Ma S: Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Med Oncol 28: 667-672, 2011.
18. Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, Sato S, Ueda R and Tajima K: Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 25: 1395-1401, 2004.
19. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H and Schmezer P: Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25: 2433-2441, 2004.
20. Su D, Ma S, Liu P, Jiang Z, Lv W, Zhang Y, Deng Q, Smith S and Yu H: Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer 56: 281-288, 2007.
21. Hadi MZ, Coleman MA, Fidelis K, Mohrenweiser HW and Wilson DM, 3rd: Functional characterization of APE1 variants identified in the human population. Nucleic Acids Res 28: 3871-3879, 2000.